TY  - JOUR

T1  - Fast-Acting Insulin Aspart Improves Glycemic Control in Basal-Bolus Treatment for Type 1 Diabetes: Results of a 26-Week Multicenter, Active-Controlled, Treat-to-Target, Randomized, Parallel-Group Trial (Onset 1).

JO  - Diabetes Care

PY  - 2017/04/11

AU  - Russell-Jones D

AU  - Bode BW

AU  - De Block C

AU  - Franek E

AU  - Heller SR

AU  - Mathieu C

AU  - Philis-Tsimikas A

AU  - Rose L

AU  - Woo VC

AU  - Østerskov AB

AU  - Graungaard T et al

ED  - 

DO  - DOI: 10.2337/dc16-1771

Y2  - 2024/10/22

ER  -